Effects of a new immunosuppressive agent, β-SQAG9, in swine kidney transplantation

Transplant Immunology

Volumn 18, Issue 1, 2007, Pages 67-71

  Tanaka, Toshiaki ^a   Kitamura, Hiroshi ^a   Sahara, Hiroeki ^a   Imai, Akihito ^a   Itoh, Yohsuke ^a   Honma, Ichiya ^a   Sato, Eiji ^a   Kobayashi, Ko ^a   Maeda, Toshihiro ^a   Takenouchi, Mika ^a   Ohta, Keisuke ^b   Sugawara, Fumio ^b   Sakaguchi, Kengo ^b   Ando, Asako ^c   Inoko, Hidetoshi ^c   Sato, Noriyuki ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

SQAG9; Kidney transplantation; Miniature swine; Tacrolimus

Indexed keywords

1,2 DI O ACYL 3 O (SULFOQUINOVOSYL)GLYCERIDE; L SELECTIN; LEUKOCYTE ANTIGEN; STEARIC ACID DERIVATIVE; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLEEDING; BLOOD CLOTTING; CAUSE OF DEATH; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYSIS; GRAFT SURVIVAL; HISTOINCOMPATIBILITY; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; LYMPHOCYTE MIGRATION; MINIPIG; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; FEMALE; GLYCOLIPIDS; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; SWINE; SWINE, MINIATURE; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34250309929     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.04.004     Document Type: Article

References (18)

1. Matsumoto Y., Sahara H., Fujita T., et al. An immunosuppressive effect by synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin. Transplantation 74 2 (2002) 261-267
2. + T-cell response in vitro via a novel sulfo-glycolipid, beta-SQAG9 liposome that binds to CD62L molecule on the cell surface. Cell Immunol 232 1-2 (2005) 105-115
3. + T-cell subset. Transplant Proc 37 1 (2005) 139-142
4. Shima H, Tsuruma T, Sahara H, et al. Protective mechanism of β-SQAG9 liposome, a sulfonoglycolipid extracted from sea urchin intestines, against hepatic ischemia reperfusion injury. Shock, in press.
5. Langone A.J., and Helderman J.H. Immunosuppression. In: Weir M.R. (Ed). Medical management of kidney transplantation (2005), Lippincott Williams and Wilkins, Philadelphia 127
6. Smith D.M., Lunney J.K., Martens G.W., et al. Nomenclature for factors of the SLA class-I system, 2004. Tissue Antigens 65 2 (2005) 136-149
7. Smith D.M., Lunney J.K., Ho C.S., et al. Nomenclature for factors of the swine leukocyte antigen class II system, 2005. Tissue Antigens 66 6 (2005) 623-639
8. Ando A., Ota M., Sada M., et al. Rapid assignment of the swine major histocompatibility complex (SLA) class I and II genotypes in Clawn miniature swine using PCR-SSP and PCR-RFLP methods. Xenotransplantation 12 2 (2005) 121-126
9. Racusen L.C., Colvin R.B., Solez K., et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 6 (2003) 708-714
10. Suzuki A., Enosawa E., Kakefuda T., et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 61 2 (1996) 200-205
11. Szebeni J., Fontana J.L., Wassef N.M., et al. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs. A model for pseudoallergic cardiopulmonary reactions to liposomes: role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 99 17 (1999) 2302-2309
12. Wassef N.M., Johnson S.H., Graeber G.M., et al. Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs. J Immunol 143 9 (1989) 2990-2995
13. Stenvinkel P. Endothelial dysfunction and inflammation - is there a link?. Nephrol Dial Transplant 16 10 (2001) 1968-1971
14. Tanabe K., Tokumoto T., Ishida H., et al. Prospective analysis of thrombotic microangiopathy after renal transplantation: comparison between cyclosporine and tacrolimus immunosuppression. Transplant Proc 34 5 (2002) 1819-1820
15. Trimarchi H.M., Truong L.D., Brennan S., Gonzalez J.M., and Suki W.N. FK506-associated thrombotic microangiopathy. Transplantation 67 4 (1999) 539-544
16. Higgins J.P.T., Montgomery K., Wang L., et al. Expression of FKBP12 in benign and malignant vascular endothelium. Am J Surg Pathol 27 1 (2003) 58-64
17. Utsugi R., Barth R.N., Lee R.S., et al. Induction of transplantation tolerance with a short course of tacrolimus (FK506). I. Rapid and stable tolerance to two-haplotype fully MHC-mismatched kidney allografts in miniature swine. Transplantation 71 10 (2001) 1368-1379
18. Treska V., Molacek J., Kobr J., Racek J., Trefil L., and Hes O. Ischemic training and immunosuppressive agents reduce the intensity of ischemic reperfusion injury after kidney transplantation. Exp Clin Transplant 4 1 (2006) 439-444